Clearside Biomedical

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$1,038
$90
$230
$6,345
Gross Profit
1,038
90
202
6,325
EBITDA
-5,156
-5,210
-9,332
-2,535
EBIT
-5,231
-5,254
-9,360
-2,555
Net Income
-7,688
-7,594
-11,763
-4,832
Net Change In Cash
1,038
90
230
6,345
Free Cash Flow
-5,966
-6,103
-7,908
375
Cash
13,888
18,238
35,355
28,920
Basic Shares
74,745
74,731
69,853
62,404

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$8,226
$1,327
$29,575
$7,894
Gross Profit
7,871
1,123
29,397
7,894
EBITDA
-23,058
-29,463
-449
-17,755
EBIT
-23,125
-29,608
-627
-17,935
Net Income
-32,485
-34,071
376
-18,030
Net Change In Cash
8,226
1,327
29,575
7,894
Cost of Revenue
17,722
13,049
-5,308
Free Cash Flow
-19,912
-13,611
-10,733
-13,175
Cash
28,920
48,258
30,436
17,287
Basic Shares
61,806
60,204
59,906
46,506

Earnings Calls

Quarter EPS
2024-09-30
-$0.10
2024-06-30
-$0.10
2024-03-31
-$0.15
2023-12-31
-$0.08